Combination Antihypertensive Therapy Among Patients With COPD
Abstract
No abstract availableKeywords
Funding Information
- Health Services Research and Development (TPM 61-037, CI-51755N)
- U.S. Department of Veterans Affairs (TPM 61-037, CI-51755N)
- American Lung Association (TPM 61-037, CI-51755N)
This publication has 31 references indexed in Scilit:
- How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?Statistics in Medicine, 2012
- The Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Diagnosis Codes for Identifying Patients Hospitalized for COPD ExacerbationsChest, 2012
- Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Circulation, 2011
- The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary diseaseBMC Health Services Research, 2011
- Combination therapy in hypertensionJournal of the American Society of Hypertension, 2010
- Heart Failure in ALLHAT: Did Blood Pressure Medication at Study Entry Influence Outcome?The Journal of Clinical Hypertension, 2009
- Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPDThe American Journal of Medicine, 2009
- Association between chronic heart failure and inhaled β-2-adrenoceptor agonistsAmerican Heart Journal, 2004
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- A General Method of Compliance Assessment Using Centralized Pharmacy RecordsMedical Care, 1988